Alternative Links zum Volltext:DOIVerlag
| Dokumentenart: | Artikel |
|---|
| Titel eines Journals oder einer Zeitschrift: | Klinische Pädiatrie |
|---|
| Verlag: | GEORG THIEME VERLAG KG |
|---|
| Ort der Veröffentlichung: | STUTTGART |
|---|
| Band: | 224 |
|---|
| Nummer des Zeitschriftenheftes oder des Kapitels: | 03 |
|---|
| Seitenbereich: | S. 197-200 |
|---|
| Datum: | 2012 |
|---|
| Institutionen: | Medizin > Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation |
|---|
| Identifikationsnummer: | | Wert | Typ |
|---|
| 10.1055/s-0032-1308986 | DOI |
|
|---|
| Stichwörter / Keywords: | LABEL DRUG-USE; CHILDHOOD-CANCER; ADULT SURVIVORS; CHILDREN; IMPACT; CARE; LEUKEMIA; AGENTS; WARDS; pediatric oncoclogy; children; phase 1 clinical trials; phase 2 clinical trials |
|---|
| Dewey-Dezimal-Klassifikation: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin |
|---|
| Status: | Veröffentlicht |
|---|
| Begutachtet: | Ja, diese Version wurde begutachtet |
|---|
| An der Universität Regensburg entstanden: | Ja |
|---|
| Dokumenten-ID: | 63765 |
|---|
Web of Science
Zusammenfassung
Pediatric oncology is an unrivaled success story in the recent history of medicine. This success is mostly based on a persistent refinement of evidence based therapeutic concepts. With that regard physicians and their staff are highly experience in the conduct of prospective evidence based trials and are therefore competent partners for the pharmaceutical industry. In times of personalized ...
Zusammenfassung
Pediatric oncology is an unrivaled success story in the recent history of medicine. This success is mostly based on a persistent refinement of evidence based therapeutic concepts. With that regard physicians and their staff are highly experience in the conduct of prospective evidence based trials and are therefore competent partners for the pharmaceutical industry. In times of personalized medicine the individual target population is diminishing and the borders of indications are not more disease based. A situation that requires new concepts from the industry. Therefore children with cancer could benefit early from the current developments as well as the pharmaceutical industry could benefit from the legislative incentives through highly recruiting and well conducted prospective trials. Pivotal is a functional platform of communication in order to maintain a close dialogue between academia and pharmaceutical companies.
Altmetric